Prolonged chronic phase of greater than 10 years of chronic myelogenous leukemia in a patient with congenital human immunodefeciency virus infection

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 658-660

  Setty, Bhuvana A ^a,b   Hayani, Karen C ^c   Sharon, Bruce I ^c   Schmidt, Mary Lou ^c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CML; HIV; Imatinib; Interferon ; Stem cell transplant

Indexed keywords

ALPHA INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BCR ABL PROTEIN; DIDANOSINE; HYDROXYUREA; IMATINIB; LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ADOLESCENT; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CHILDHOOD CANCER; CHRONIC MYELOID LEUKEMIA; CHRONICITY; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; LEUKOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL; PANCREATITIS; PATIENT COMPLIANCE; PATIENT MONITORING; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; SHORT STATURE; UPPER RESPIRATORY TRACT INFECTION; MYELOID LEUKEMIA; TIME;

ADOLESCENT; HIV INFECTIONS; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; TIME FACTORS;

EID: 69849091303     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22096     Document Type: Article

References (10)

1. Pui C-H. Childhood leukemias, 2nd edition. New York: Cambridge University Press. pp. 582-596.
2. Behrman RE, Kliegman RM, Jenson HB. Nelson textbook of pediatrics, 17th edition. 2003. pp. 1697-1698.
3. Pizzo PA, Poplack DG. Principles and practice of pediatric oncology, 3rd edition. Philadelphia: Lippincott-Raven. 1997. pp. 645-672.
4. Champagne MA, Capdeville R, Krailo M, et al. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: Results from a Children's Oncology Group phase 1 study. Blood 2004;104:2655-2660. (Pubitemid 39434944)
5. Champagne MA, Fu C, Chang M, et al. Imatinib in children with newly diagnosed chronic phase chronic myelogenous leukemia. Blood 2006;108: Abstract 2140.
6. Millot F, Guilhot J, Nelken B, et al. Imatinib is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation. Leukemia 2006;20:187-192. (Pubitemid 43148651)
7. Mwangi JW. HIV-associated lymphoma: Report of three cases. East Afr Med J 1999;76:176-177.
8. Kest H, Brogly S, McScherry G, et al. Malignancy in perinatally human immunodefeciency virus-infected children in the United States. Pediatr Infect Dis J 2005;24:237-242. (Pubitemid 40365858)
9. Pollock BH, Jenson HB, Leach CT, et al. Risk factors for pediatric human immunodeficiency virus related malignancy. JAMA 2003;289:2393-2399. (Pubitemid 37430172)
10. Verneris MR, Tuel L, Seibel NL. Pediatric HIV and chronic myelogenous leukemia. Pediatr AIDS HIV Infect 6:292-294.